I can see a few biotechs in there I wouldn’t touch with someone else’s appendage, so I would take this list as a grain of salt.
DXB though is making amazing progress In Ph3 trials in Orphan Disease.
@singhgu yes I am really wanting some news soon as well on COVID-19 trial data, some compelling independent & recent data out on inflammation, the RAS pathway & inflammatory biomarkers (MCP-1). I’m out today, so please take a look.
Ann: Investor Presentation, page-22
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.8¢ |
Change
0.023(5.17%) |
Mkt cap ! $249.1M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 46.5¢ | 42.5¢ | $947.8K | 2.138M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 61890 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 83983 | 8 |
View Market Depth
| Last trade - 14.54pm 31/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |